The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Defibrase Treatment of Cerebral Infarction:Therapeutic Effectiveness and Related Factors
Author(s): 
Pages: 135-136
Year: Issue:  3
Journal: JOURNAL OF YUNYANG MEDICAL COLLEGE

Keyword:  脑梗塞纤维蛋白溶解药治疗结果;
Abstract: 目的:观察精制去纤酶治疗脑梗塞的疗效 ,并探讨影响疗效的有关因素.方法:50例病程在3~72h内脑梗塞静脉滴注精制去纤酶,首剂2 Bu,第3、5、7 d各用1 Bu;根据临床及实验室资料对其疗效进行多因素分析.结果:总有效率78%,在24 h内治疗的有效率为81 .9%,与25~72h内治疗的疗效相比有显著性差异(P<0.05),治疗后血纤维蛋白原、血浆粘度明显降低.多因素分析表明:疗效除与治疗时间有关外,还与病情程度、血糖水平有关,与年龄、性别、入院时血压、血脂水平等因素无关.结论:精制去纤酶治疗用于病情轻-中度,尤其是伴高纤维蛋白原血症的脑梗塞患者,应用越早,效果越明显.
Related Articles
loading...